檢索結果 - V. Sandor
- Showing 1 - 4 results of 4
-
1
-
2
A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis 由 Alessandro M. Vannucchi, H. Kantarjian, Jean‐Jacques Kiladjian, Jason Gotlib, F. Cervantes, Ruben A. Mesa, Nicholas J. Sarlis, Wei Peng, V. Sandor, P. Gopalakrishna, Abdel Hmissi, Viktoriya Stalbovskaya, Vikas Gupta, Claire Harrison, Srđan Verstovšek
出版 2015Artigo -
3
Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I 由 Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib, R. S. Levy, Vikas Gupta, John F. DiPersio, John Catalano, Michael W. Deininger, Carole B. Miller, Richard T. Silver, Moshe Talpaz, E. Winton, Jimmie H. Harvey, Murat O. Arcasoy, Elizabeth O. Hexner, Roger M. Lyons, Azra Raza, Kris Vaddi, William Sun, Wei Peng, V. Sandor, Hagop M. Kantarjian
出版 2015Artigo -
4
Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I 由 Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib, Richard S. Levy, Vikas Gupta, John F. DiPersio, John Catalano, Michael W. Deininger, Carole B. Miller, Richard T. Silver, Moshe Talpaz, E. Winton, Jimmie H. Harvey, Murat O. Arcasoy, Elizabeth O. Hexner, Roger M. Lyons, Ronald Paquette, Azra Raza, Kris Vaddi, Susan Erickson‐Viitanen, William Sun, V. Sandor, H. Kantarjian
出版 2013Artigo
相關主題
Bone marrow
Internal medicine
Medicine
Myelofibrosis
Ruxolitinib
Surgery
Alternative medicine
Confidence interval
Hazard ratio
Pathology
Placebo
Anemia
Biochemistry
Biology
CDK inhibitor
Cancer
Cancer research
Cell biology
Cell cycle
Crossover study
Cyclin B
Cyclin D1
Cyclin-dependent kinase
Cyclin-dependent kinase 2
Gastroenterology
Gene
Genetics
Histone
Histone deacetylase
Histone deacetylase inhibitor